Drug:
Reaction: THERAPY INTERRUPTED
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26943068 |
64 | 1 | |
Hospitalisation, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 102 | 26943113 |
64 | 1 | |
Hospitalisation, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 103 | 26943115 |
72 | 1 | |
Therapy interrupted, |
||||
AVACOPAN, |
||||
| 104 | 26943120 |
81 | 2 | |
White blood cell count decreased, Sepsis, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 105 | 26943123 |
74 | 1 | |
Hospitalisation, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 106 | 26943356 |
|||
Nasopharyngitis, Therapy interrupted, Oropharyngeal pain, Upper respiratory tract infection, Cardiac disorder, Hypertension, Heart rate increased, |
||||
UPADACITINIB, |
||||
| 107 | 26943362 |
2 | ||
Erythema, Dyspnoea, Central nervous system lesion, Therapy interrupted, |
||||
GLATIRAMER ACETATE, DIROXIMEL FUMARATE, DIMETHYL FUMARATE, OFATUMUMAB, OXYCODONE, |
||||
| 108 | 26943363 |
72 | 2 | |
Therapy interrupted, Knee arthroplasty, |
||||
SECUKINUMAB, |
||||
| 109 | 26943521 |
1 | ||
Atrial fibrillation, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 110 | 26943522 |
62 | 2 | |
General physical health deterioration, Oral disorder, Therapy interrupted, |
||||
EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT), EPINEPHRINE, ADRENALINUM, |
||||
| 111 | 26945323 |
67 | 2 | |
Atrial fibrillation, Bradycardia, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 112 | 26945404 |
62 | 2 | |
General physical health deterioration, Dyskinesia, Therapy interrupted, |
||||
EPINEPHRINE, ADRENALINUM, EFGARTIGIMOD ALFA, |
||||
| 113 | 26945561 |
73 | 2 | |
Cerebral haemorrhage, Blood pressure abnormal, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 114 | 26931504 |
US |
2 | |
Seizure, Insurance issue, Therapy interrupted, |
||||
BRIVARACETAM, CENOBAMATE, |
||||
| 115 | 26931543 |
US |
19 | 2 |
Product dose omission in error, Therapy interrupted, |
||||
MAVACAMTEN, |
||||
| 116 | 26931787 |
US |
48 | 2 |
Ankylosing spondylitis, Rheumatoid arthritis, Psoriatic arthropathy, Insurance issue, Therapy interrupted, Off label use, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, SARILUMAB, |
||||
| 117 | 26931851 |
US |
1 | |
Ankylosing spondylitis, Therapy interrupted, Insurance issue, Product use in unapproved indication, Disease susceptibility, Spinal osteoarthritis, Condition aggravated, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 118 | 26931942 |
US |
68 | |
Product dose omission issue, Product availability issue, Off label use, Intentional product use issue, Treatment noncompliance, Therapy interrupted, |
||||
PALTUSOTINE, PALTUSOTINE, MONTELUKAST, ROSUVASTATIN, SOTALOL HYDROCHLORIDE, |
||||
| 119 | 26931953 |
US |
56 | |
Intentional underdose, Therapy interrupted, Insurance issue, Off label use, |
||||
PALTUSOTINE, |
||||
| 120 | 26931980 |
US |
56 | |
Therapy interrupted, |
||||
PALTUSOTINE, |
||||
| 121 | 26932026 |
US |
58 | |
Therapy interrupted, Product prescribing issue, |
||||
PALTUSOTINE, PALTUSOTINE, |
||||
| 122 | 26932635 |
US |
48 | 1 |
Psoriasis, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 123 | 26932718 |
US |
46 | 1 |
Inappropriate schedule of product administration, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 124 | 26933088 |
US |
2 | |
Therapy interrupted, |
||||
BRENSOCATIB, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FLUTICASONE PROPIONATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ALBUTEROL SULFATE, |
||||
| 125 | 26933323 |
CA |
57 | |
Pharyngeal swelling, Ear swelling, Abdominal tenderness, Malaise, Pallor, Dyspnoea exertional, Chest discomfort, Nausea, Hypertension, Tachycardia, Therapy interrupted, |
||||
OMALIZUMAB, FEXOFENADINE, |
||||
| 126 | 26933590 |
US |
60 | 2 |
Myocardial infarction, Therapy interrupted, |
||||
EVOLOCUMAB, |
||||
| 127 | 26933759 |
US |
65 | 2 |
Therapy interrupted, Adverse event, |
||||
LENALIDOMIDE, |
||||
| 128 | 26933932 |
US |
59 | 2 |
Product prescribing issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 129 | 26933942 |
US |
14 | |
Therapy interrupted, |
||||
ISOTRETINOIN, |
||||
| 130 | 26933958 |
CA |
37 | |
Concussion, COVID-19, Sinusitis, Intentional dose omission, Therapy interrupted, Intentional product use issue, Inappropriate schedule of product administration, Product distribution issue, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 131 | 26937240 |
55 | 2 | |
Cellulitis, Cellulitis, Sepsis, Goitre, Tracheal deviation, Therapy interrupted, Urinary tract infection, |
||||
DASATINIB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 132 | 26937685 |
69 | 2 | |
Fall, Limb injury, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 133 | 26937819 |
63 | 2 | |
Fall, Therapy interrupted, |
||||
TERIPARATIDE, |
||||
| 134 | 26938069 |
70 | 2 | |
Brain fog, Therapy interrupted, Dizziness, Disorientation, Confusional state, Lethargy, |
||||
TENAPANOR HYDROCHLORIDE, |
||||
| 135 | 26927051 |
US |
2 | |
Rheumatoid arthritis, Therapy interrupted, Intentional product misuse, Dyspnoea, |
||||
ETANERCEPT, |
||||
| 136 | 26927302 |
US |
2 | |
Hospitalisation, Therapy interrupted, |
||||
BRENSOCATIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CELECOXIB, DONEPEZIL HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, IPRATROPIUM BROMIDE, ITRACONAZOLE, EMPAGLIFLOZIN, LOSARTAN, MAGNESIUM OXIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, PIOGLITAZONE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, RIFAMPIN, ROSUVASTATIN, CINACALCET HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, |
||||
| 137 | 26927330 |
US |
64 | 2 |
Syncope, Blindness transient, Dyspnoea, Anaemia, Fatigue, Nausea, Therapy interrupted, Blood creatinine increased, Glomerular filtration rate decreased, Product dose omission in error, |
||||
OLAPARIB, OLAPARIB, OLAPARIB, |
||||
| 138 | 26927529 |
US |
||
Product preparation issue, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 139 | 26927787 |
62 | 1 | |
Limb operation, Arthrodesis, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 140 | 26927790 |
US |
56 | 1 |
Therapy interrupted, Product distribution issue, |
||||
MAVACAMTEN, |
||||
| 141 | 26928220 |
US |
84 | |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 142 | 26928701 |
CA |
1 | |
Rheumatoid arthritis, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 143 | 26928749 |
US |
2 | |
Therapy interrupted, |
||||
TILDRAKIZUMAB-ASMN, |
||||
| 144 | 26929125 |
US |
2 | |
Renal impairment, Drug ineffective, Therapy interrupted, Vomiting, Diarrhoea, |
||||
CHLORTHALIDONE, |
||||
| 145 | 26929512 |
US |
||
Therapy interrupted, Insurance issue, |
||||
BRENSOCATIB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 146 | 26929513 |
US |
2 | |
Psoriasis, Insurance issue, Stress, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 147 | 26929521 |
US |
1 | |
Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 148 | 26929566 |
US |
2 | |
Therapy interrupted, Insurance issue, |
||||
BRENSOCATIB, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), GABAPENTIN, LINACLOTIDE, METOLAZONE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, OLANZAPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ERGOCALCIFEROL, RIVAROXABAN, |
||||
| 149 | 26929597 |
US |
1 | |
Therapy interrupted, |
||||
BRENSOCATIB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MOMETASONE FUROATE, MOMETASONE, ALBUTEROL SULFATE, ALBUTEROL, PREDNISONE, ERGOCALCIFEROL, CALCIUM, LEUPROLIDE ACETATE, |
||||
| 150 | 26929598 |
US |
75 | 1 |
Mental disorder, Therapy interrupted, |
||||
BRENSOCATIB, ALPRAZOLAM, AMOXICILLIN AND CLAVULANATE POTASSIUM, INSULIN GLARGINE, BENZONATATE, FUROSEMIDE, GABAPENTIN, PIOGLITAZONE, ROSUVASTATIN, FOLIC ACID, |
||||
| 151 | 26929655 |
US |
2 | |
Therapy interrupted, |
||||
BRENSOCATIB, BRENSOCATIB, |
||||
| 152 | 26929687 |
US |
1 | |
Product distribution issue, Therapy interrupted, |
||||
BRENSOCATIB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 153 | 26929690 |
US |
87 | |
Haemorrhage, Therapy interrupted, Therapy cessation, Adverse drug reaction, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 154 | 26929744 |
US |
2 | |
Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 155 | 26929781 |
US |
2 | |
Therapy interrupted, |
||||
BRENSOCATIB, ALBUTEROL SULFATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FLUTICASONE PROPIONATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 156 | 26929789 |
US |
2 | |
Breast pain, Back pain, Insurance issue, Therapy interrupted, |
||||
BRENSOCATIB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, GABAPENTIN, FAMOTIDINE, AMLODIPINE BESYLATE, MONTELUKAST SODIUM, PANTOPRAZOLE SODIUM, ESCITALOPRAM, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 157 | 26929792 |
US |
1 | |
Product distribution issue, Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 158 | 26929822 |
US |
1 | |
Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 159 | 26929833 |
US |
2 | |
Anxiety, Therapy interrupted, |
||||
BRENSOCATIB, BRENSOCATIB, AMIKACIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, SPIRONOLACTONE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 160 | 26929839 |
US |
1 | |
Adverse event, Therapy interrupted, |
||||
BRENSOCATIB, ALBUTEROL SULFATE, ALBUTEROL, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, FUROSEMIDE, ATORVASTATIN CALCIUM, PRIMIDONE, OMEPRAZOLE MAGNESIUM, FINASTERIDE, METOPROLOL SUCCINATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 161 | 26929847 |
US |
2 | |
Drug screen false positive, Therapy interrupted, Product use in unapproved indication, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 162 | 26930047 |
US |
1 | |
Therapy interrupted, |
||||
BRENSOCATIB, LORATADINE, LORATADINE TABLET, FLUTICASONE PROPIONATE, EMPAGLIFLOZIN, LOSARTAN, ROSUVASTATIN, MONTELUKAST SODIUM, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ERGOCALCIFEROL, |
||||
| 163 | 26930063 |
US |
2 | |
Therapy interrupted, Hospice care, |
||||
BRENSOCATIB, |
||||
| 164 | 26930075 |
US |
2 | |
Product supply issue, Therapy interrupted, |
||||
BRENSOCATIB, ALPRAZOLAM, DOXEPIN, DOXEPIN HYDROCHLORIDE, OXCARBAZEPINE, OXYCODONE, |
||||
| 165 | 26930108 |
US |
1 | |
Arthritis, Psoriasis, Therapy interrupted, Insurance issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 166 | 26930135 |
CA |
41 | 1 |
Hospitalisation, Pain, Therapy interrupted, |
||||
BRODALUMAB, BRODALUMAB, FOLIC ACID, DESONIDE, |
||||
| 167 | 26930467 |
69 | 1 | |
Rash, Therapy interrupted, |
||||
IMATINIB, |
||||
| 168 | 26930520 |
US |
66 | |
Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 169 | 26930521 |
US |
2 | |
Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 170 | 26930528 |
US |
2 | |
Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 171 | 26930554 |
US |
1 | |
Therapy interrupted, Off label use, |
||||
BRENSOCATIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DAPAGLIFLOZIN, FINASTERIDE, LOSARTAN, MAGNESIUM OXIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, PREDNISONE, IPRATROPIUM BROMIDE, |
||||
| 172 | 26930555 |
US |
2 | |
Therapy interrupted, |
||||
BRENSOCATIB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, SERTRALINE, IRON, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, TOBRAMYCIN, TOBRAMYCIN SOLUTION, TOBRAMYCIN SULFATE, ALBUTEROL SULFATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 173 | 26930594 |
69 | 1 | |
Stomatitis, Squamous cell carcinoma, Therapy interrupted, |
||||
RUXOLITINIB, RUXOLITINIB, |
||||
| 174 | 26930603 |
US |
2 | |
Sputum increased, Product prescribing issue, Therapy interrupted, |
||||
BRENSOCATIB, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL, PANTOPRAZOLE, |
||||
| 175 | 26930612 |
US |
2 | |
Anaesthesia procedure, Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 176 | 26930618 |
US |
2 | |
Therapy interrupted, |
||||
BRENSOCATIB, BUPROPION, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BIMATOPROST, NASAL, SODIUM CHLORIDE, SALINE, SALINE NASAL SPRAY, (SALINE), |
||||
| 177 | 26930632 |
US |
2 | |
Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 178 | 26930790 |
|||
Drug ineffective, Therapy interrupted, |
||||
TIRZEPATIDE, |
||||
| 179 | 26930797 |
68 | 2 | |
Fall, Pneumonia, Urinary tract infection, Haematological infection, Therapy interrupted, Malaise, |
||||
DEUTETRABENAZINE, |
||||
| 180 | 26930902 |
US |
57 | 1 |
Crohn^s disease, Insurance issue, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 181 | 26930997 |
US |
39 | 2 |
Arthralgia, Pruritus, Therapy interrupted, Insurance issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 182 | 26931013 |
1 | ||
Hospitalisation, Therapy interrupted, |
||||
LENALIDOMIDE, ACYCLOVIR, CALCIUM ACETATE, CYANOCOBALAMIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, EPOETIN ALFA, FINASTERIDE, GABAPENTIN, |
||||
| 183 | 26931027 |
2 | ||
Rheumatoid arthritis, Gout, Pneumonia, Cellulitis, Therapy interrupted, Infection, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, PREDNISONE, |
||||
| 184 | 26931073 |
77 | 2 | |
Sepsis, Pneumonia, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 185 | 26931075 |
79 | 2 | |
Food poisoning, Pneumonia, Therapy interrupted, |
||||
MAVACAMTEN, |
||||
| 186 | 26936712 |
1 | ||
Therapy change, Therapy interrupted, |
||||
LENALIDOMIDE, ALLOPURINOL, ALPRAZOLAM, AMLODIPINE, CYANOCOBALAMIN, ERGOCALCIFEROL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 187 | 26936885 |
38 | 2 | |
Urticaria, Swelling face, Inflammation, Therapy interrupted, Nonspecific reaction, |
||||
CANAKINUMAB, ANAKINRA, |
||||
| 188 | 26937214 |
70 | 1 | |
Muscle spasms, Blood glucose fluctuation, Therapy interrupted, Abdominal pain upper, Diarrhoea, Hereditary angioedema, Therapy cessation, Dehydration, |
||||
ICATIBANT, LANADELUMAB-FLYO, |
||||
| 189 | 26921366 |
CO |
66 | 2 |
Colitis, Therapy interrupted, Headache, Tinnitus, Hypoacusis, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 190 | 26921637 |
US |
74 | |
Therapy interrupted, Infection, Adverse event, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 191 | 26921950 |
CA |
62 | |
Knee arthroplasty, Crohn^s disease, Feeling abnormal, Nausea, Gastrointestinal infection, Therapy interrupted, Intentional dose omission, Suspected off label use, Underdose, |
||||
INFLIXIMAB-DYYB, ADALIMUMAB-AATY, ADALIMUMAB-AATY, MESALAMINE, |
||||
| 192 | 26921988 |
US |
65 | 1 |
Therapy interrupted, Quality of life decreased, |
||||
ETANERCEPT, |
||||
| 193 | 26922121 |
US |
51 | 1 |
Pain, Dystonia, On and off phenomenon, Muscle tightness, Musculoskeletal stiffness, Speech disorder, Product distribution issue, Therapy interrupted, |
||||
ENTACAPONE, ROPINIROLE, FUROSEMIDE, DABIGATRAN ETEXILATE MESYLATE, DABIGATRAN ETEXILATE, LOSARTAN, |
||||
| 194 | 26922126 |
US |
59 | 1 |
Rheumatoid arthritis, Therapy interrupted, Insurance issue, |
||||
ABATACEPT, |
||||
| 195 | 26922496 |
US |
72 | 1 |
Deafness, Therapy interrupted, |
||||
RELUGOLIX, |
||||
| 196 | 26922507 |
US |
2 | |
Transient ischaemic attack, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 197 | 26922673 |
US |
58 | 2 |
Psoriatic arthropathy, Insurance issue, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 198 | 26922692 |
US |
71 | 2 |
Product prescribing error, Therapy interrupted, |
||||
POMALIDOMIDE, |
||||
| 199 | 26923109 |
US |
65 | |
Therapy interrupted, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 200 | 26923222 |
US |
2 | |
Rash, Therapy non-responder, Discomfort, Therapy interrupted, |
||||
APREMILAST, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
